This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tuskegee University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Detection by Inventor Kelvin Jones
Introduction
Kelvin Jones is an accomplished inventor based in Tuskegee, Alabama. He has made significant contributions to the field of cancer research, particularly in the detection of breast cancer. His innovative work focuses on the identification of epithelial to mesenchymal transition (EMT) phenotypic cells, which are crucial in understanding cancer progression.
Latest Patents
Kelvin Jones holds a patent for "Methods and compositions for the identification of epithelial to mesenchymal breast cancer." This patent describes a method for selectively detecting EMT phenotypic cells while avoiding noncancerous epithelial cells and breast fibroblasts in biological samples. The compositions include novel binding peptides that specifically target EMT cancer cells. These peptides can be used to quantitatively measure the presence of EMT cells through a detectable marker. Additionally, the patent discusses the use of nanodevices that incorporate specific EMT phage ligands to identify EMT cancer cells in vivo.
Career Highlights
Kelvin Jones is affiliated with Tuskegee University, where he conducts research and develops innovative solutions in cancer detection. His work has garnered attention for its potential to improve diagnostic methods and patient outcomes in breast cancer treatment.
Collaborations
Kelvin collaborates with Deepa Bedi, who is also involved in research related to cancer detection and treatment. Their partnership enhances the scope and impact of their work in the field.
Conclusion
Kelvin Jones is a notable inventor whose work in cancer detection is paving the way for advancements in medical diagnostics. His innovative methods and compositions hold promise for improving the identification of breast cancer cells, ultimately benefiting patient care.